Ser154; #3139-FB) were obtained from R&D Systems (Minneapolis, MN, USA). Purified recombinant C-terminal FGF23 fragment, Ser180-Val251 (N-terminal His-tagged, expressed in E. coli), was generated as a custom synthesis by Genscript (Piscataway, NJ, USA). We confirmed the biological activity of the recombinant mouse FGF23 by demonstrating a specific dose-dependent increase in Erg1 and SRE luciferase reporter activity in HEK293 cells transiently expressing V5-tagged membrane αKl ( Supplementary Fig. S5 ). This is consistent with previous reports by other authors 4, 5 , which have shown this source of recombinant protein to have biological activity in vitro (Erg1/Erk induction) and in vivo (i.e. phosphaturic).
Inhibitors used, and their final concentrations are listed in SupplementaryTable S1.
None of the compounds were found to significantly reduce cell viability (MTT assay) over 24h, when used at the stated concentrations. Primary and secondary antibodies used are listed in Supplementary Table S2 and Supplementary Table S3 respectively.
Immunoperoxidase staining
Adjacent portions of renal tissue were fixed in methyl carnoys or 4% paraformaldehyde in phosphate buffered saline (PBS), processed and embedded in paraffin wax. For DAB immunohistochemistry, tissue sections were dewaxed in xylene, rehydrated in graded alcohol, endogenous peroxidase activity was quenched using 3% H 2 O 2 in water for 30 min, before nonspecific binding sites were blocked with 10% normal horse serum for a further 30 min at RT (Vector Laboratories, Burlinghame, CA, USA). Sections were then incubated with rabbit polyclonal anti-collagen I (methyl caronys) or rabbit monoclonal anti-vimentin (4% paraformaldehyde). In each case, antibody binding was visualised using an avidin-biotincomplex (ABC Elite; Vector Laboratories) and 3,3'-diaminobenzidine (DAB; Sigma). For detection of α -smooth muscle actin, parformaldehyde fixed sections were prepared as above and then incubated with mouse monoclonal αSMA, conjugated to biotin (ARK kit; Dako), and incubated with streptavidin peroxidase (ARK) and DAB. Finally sections were counterstained with haematoxylin (Dako), dehydrated, and mounted in DePex (Merck) 6 . Images were taken using an Olympus BX50 microscope using 10x magnification.
Immunofluorescence staining
For immunofluorescent co-staining of FGF23 and Lotus tetragonolobus lectin (LTL), parformaldehyde fixed sections were boiled under pressure in citrate buffer (pH 6.0), equilibrated in PBS for 30 min and free aldehyde groups reduced by immersion in NH 4 Cl (50 mmol/L) in PBS for 20 min at room temperature. Non-specific binding sites were blocked with 10% goat serum (Vector laboratories) in 3% BSA/PBS (pH 7.6) containing 0. Vectashield (#H-1400; Vector laboratories). Low power images were taken using a Zeiss AXIOSKOP2 microscope using 0.75x or 20x magnification or visualised on a Leica SP5 confocal microscope with a 63x oil objective for high power imaging. Post-acquisition processing was performed using Fiji-ImageJ (NIH).
The mouse FGF-23 antibody (#MAB2629; R&D systems) used here has been employed in the IHC detection of FGF23 in multiple rodent studies 7, 8 , including ectopic detection in the kidney 9 . Specificity was confirmed here by blocking studies using antiserum pre-absorbed with a 10 molar excess of the immunising peptide (#2629-FG; R&D systems).
After centrifugation, the supernatant was used at the same working dilution, and in parallel with anti-FGF23 staining, as above ( Supplementary Fig.S6 ). Comparison of immunohistochemical detection without amplification using SuperBoost is also shown alongside.
Laser capture microdissection
Laser Capture Microdissection (LCMD) was used to isolate specific nephron segments from fixed paraffin embedded tissue sections using the Veritas™ instrument and Arcturus reagents (Mountain View, CA, USA) 10 .
Paraffin wax embedded methyl carnoys fixed tissue blocks prepared above were resectioned at 5-10µm. Sections were collected on RNase free plastic slides (Arcturus). The slides were de-waxed using RNase-free techniques, and stained using the HistoGene kit (Arcturus) to provide differential contrast for subsequent micro-dissection. 
Fibroblast culture and treatments
Primary cultures of fibroblasts propagated from normal kidneys (NRKF) and fibrotic kidneys (3 days after UUO; UUOF) of Sprague-Dawley rats were utilised for these studies, as described before 12 . Cultures were maintained in Dulbecco's modified Eagle Medium (DMEM) supplemented with 10% foetal bovine serum (FBS), 2.2% HEPES, 1% L-glutamine, penicillin (50 U/mL) and streptomycin (50 µg/mL) in a humidified incubator at 37˚C and 5% were captured with a Leica SP5 confocal microscope using a 63x oil immersion objective.
Cell transfection and luciferase reporter assays
Transient gene silencing in UUOF was performed using pre-designed siRNA (13 nM Table S4 ). PCR conditions were set according to the manufacturer's instructions. Melt curve analysis was performed to verify the purity and specificity of the amplicons. Direct sequencing was used to confirm the specific amplification of FGF23 transcripts in whole kidney lysates and LCMD tissue. Threshold cycles were calculated using CFX Manager Software (Bio-Rad), and the mRNA level of target genes was normalised to the reference gene, β-actin, and expressed relative to an appropriate control (D0 or vehicle-treated) using the 2^(−ΔΔCt) method. For detection analyses, PCR products were resolved on 10% TBE pre-cast gels and visualised with SYBR Safe DNA gel stain (Invitrogen, Carlsbad, CA, USA) on a ChemiDoc MP imaging platform (Bio-Rad).
For LCMD tissue, RNA extraction and purification was performed using the Paradise PLUS Reagent System (Arcturus) according to the manufacturer's instructions with modifications as described previously 10 . The quality of the extracted RNA was assessed using the Paradise Quality Assessment kit with the ratio of 3'-and 5'-directed b-actin transcripts <10. First and second strand cDNA was synthesised using Superscript III RT (Invitrogen) and purified, before Whole Transcriptome Amplification (Arcturus) and purification of the amplified RNA. A second round of cDNA synthesis was performed to generate the template for gene expression.
RT 2 Profiler PCR array
Total RNA was isolated from 25cm 2 flasks of vehicle-, FGF23-or TGFβ 1 -treated cultures of NRKF and UUOF as previously described and reverse-transcribed using the RT 
Western blot analysis
Western blotting studies were performed as previously described 15 . For protein extraction from isolated mouse tissue, samples were minced and then homogenised using a 
Statistics
Results were analysed by one-way ANOVA with Holm-Sidak multiple comparisons test when comparing 3 or more groups or using a two-tailed unpaired Student's t-test when comparing 2 groups (GraphPad Prism 7.0, La Jolla, CA, USA). All data in this paper are presented as the mean ± SD with P < 0.05 defined as statistically significant. 
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